BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 33883002)

  • 1. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modification in diabetic kidney disease.
    Liu Z; Liu J; Wang W; An X; Luo L; Yu D; Sun W
    Front Endocrinol (Lausanne); 2023; 14():1133970. PubMed ID: 37455912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic kidney diseases revisited: A new perspective for a new era.
    Fu H; Liu S; Bastacky SI; Wang X; Tian XJ; Zhou D
    Mol Metab; 2019 Dec; 30():250-263. PubMed ID: 31767176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations.
    Xu L; Natarajan R; Chen Z
    Curr Diab Rep; 2019 Feb; 19(3):9. PubMed ID: 30730019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.
    Sun J; Wang Y; Cui W; Lou Y; Sun G; Zhang D; Miao L
    J Diabetes Res; 2017; 2017():7242384. PubMed ID: 28695133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.
    Hirakawa Y; Tanaka T; Nangaku M
    J Diabetes Investig; 2017 May; 8(3):261-271. PubMed ID: 28097824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting DNA methylation in diabetic kidney disease: A new perspective.
    Akhouri V; Majumder S; Gaikwad AB
    Life Sci; 2023 Dec; 335():122256. PubMed ID: 37949210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study.
    Smyth LJ; Kilner J; Nair V; Liu H; Brennan E; Kerr K; Sandholm N; Cole J; Dahlström E; Syreeni A; Salem RM; Nelson RG; Looker HC; Wooster C; Anderson K; McKay GJ; Kee F; Young I; Andrews D; Forsblom C; Hirschhorn JN; Godson C; Groop PH; Maxwell AP; Susztak K; Kretzler M; Florez JC; McKnight AJ
    Clin Epigenetics; 2021 May; 13(1):99. PubMed ID: 33933144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in the pathogenesis of diabetic nephropathy.
    Li X; Lu L; Hou W; Huang T; Chen X; Qi J; Zhao Y; Zhu M
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):163-172. PubMed ID: 35130617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine RNA methylation in diabetic kidney disease.
    Huang J; Yang F; Liu Y; Wang Y
    Biomed Pharmacother; 2024 Feb; 171():116185. PubMed ID: 38237350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis.
    Kuo FC; Chao CT; Lin SH
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress as a culprit in diabetic kidney disease.
    Su S; Ma Z; Wu H; Xu Z; Yi H
    Life Sci; 2023 Jun; 322():121661. PubMed ID: 37028547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Histone Modifications in the Pathogenesis of Diabetic Kidney Disease.
    Lu HC; Dai WN; He LY
    Diabetes Metab Syndr Obes; 2021; 14():329-344. PubMed ID: 33519221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
    Guo J; Liu Z; Gong R
    Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology.
    Morgado-Pascual JL; Marchant V; Rodrigues-Diez R; Dolade N; Suarez-Alvarez B; Kerr B; Valdivielso JM; Ruiz-Ortega M; Rayego-Mateos S
    Mediators Inflamm; 2018; 2018():2931049. PubMed ID: 30647531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H; Kulkarni YA; Gaikwad AB
    Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications in metabolic memory: What are the memories, and can we erase them?
    Chen Z; Natarajan R
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C570-C582. PubMed ID: 35785987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modifications in the pathogenesis of diabetic nephropathy.
    Reddy MA; Tak Park J; Natarajan R
    Semin Nephrol; 2013 Jul; 33(4):341-53. PubMed ID: 24011576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis.
    Hung PH; Hsu YC; Chen TH; Lin CL
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.